PGAM1 and non-small cell lung carcinoma: In addition, PGAM1 is overexpressed in multiple cancers (Li and Liu, 2020), including ovarian cancer (Zhang et al., 2020), non–small-cell lung cancer (NSCLC) (Li et al., 2020), colorectal cancer (Liu et al., 2008; Lei et al., 2011), pancreatic ductal adenocarcinoma (PDAC) (Liu et al., 2018), prostate cancer (PCa) (Wen et al., 2018), and glioma (Xu et al., 2016).